Practical eminence and experience-based recommendations for treatment of sarcoidosis

M. Drent (Ede, The Netherlands), U. Costabel (Essen, Germany)

Source: CME Online 2014
Number: 100028
Disease area: Interstitial lung diseases

CME test or case report

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Drent (Ede, The Netherlands), U. Costabel (Essen, Germany). Practical eminence and experience-based recommendations for treatment of sarcoidosis. CME Online 2014

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERS guidelines on treatment of sarcoidosis
Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis
Year: 2021


Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019

Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists?
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Clinical use of interstitial lung disease guidelines
Source: Eur Respir Mon; 2009: 46: 386–395
Year: 2009

COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Source: ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Year: 2020


The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Clinical highlights from the 2011 ERS Congress in Amsterdam
Source: Eur Respir J 2012; 39: 1501-1510
Year: 2012



Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology
Source: Eur Respir Rev 2013; 22: 117-123
Year: 2013



Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Selected clinical highlights from the 2012 ERS congress in Vienna
Source: Eur Respir J 2013; 41: 1219-1227
Year: 2013



Development of the interstitial lung disease multidiciplinary team meeting 2005-2013
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015

Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020
Year: 2020



Case for diagnosis
Source: Annual Congress 2005 - Paediatric Clinical Grand Round: an interactive session
Year: 2005

Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



Demonstration of diagnostic and prognostic benefits of an interstitial lung disease (ILD) multidisciplinary team meeting
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011